Hemostats Market Research Report Data by Product (Active Hemostats, Passive Hemostats, Combination Hemostats, and Others), Application (Trauma, Cardiovascular Surgery, General Surgery, Plastic Surgery, Orthopedic Surgery, Neurosurgery and Others), End User (Hospitals & ASCs, Tactical Combat Casualty Care Centers, and Others), Region (North America, Europe, Asia Pacific, South America, Middle East and Africa), Global trends and forecast from 2024 to 2030

Hemostats Market Outlook (2024 to 2030)

The global Hemostats market is expected to grow at 6.6% CAGR from 2024 to 2030. It is expected to reach above USD 4.51 billion by 2030 from USD 2.54 billion in 2023.

Hemostats are devices that compress blood vessels and prevent blood or other fluids from flowing. They are typically used to control bleeding during surgical procedures. Hemostatic agents have a number of advantages, including faster wound healing and operative time, better management of anticoagulated patients, and a shorter recovery time for patients. There is a wide variety of surgical hemostatic agents on the market, each with its own composition, cost, immunogenicity, mechanism of action, application, and adherence. 

There has been an increase in the demand for hemostats as the prevalence of chronic diseases, caesarean deliveries, fatal injuries, and major organ surgeries has increased. These medications help patients with hemostatic abnormalities and nonanatomic and sensitive structures avoid blood loss during surgical procedures. Aside from that, their use helps to reduce procedure costs, which has led to their widespread adoption among healthcare providers. Furthermore, as a result of technological advancements, leading manufacturers have developed absorbable adjunctive hemostats that assist professionals in controlling disruptive bleeding more effectively than traditional methods. 

They are also using nano- and micro-materials to treat uncontrolled hemorrhage and internal bleeding. Advanced laparoscopic hemostats have also been introduced by market participants to improve the quality of surgical operations and allow for less invasive procedures. Improvements in healthcare facilities, as well as extensive research and development (R&D) activities to launch new products, are also having a positive impact on the industry. Hemostat is a chemical agent that prevents excessive blood flow and is used to close wounds. Hemostats are highly effective blood loss control devices used during surgeries and operations. Sponge, gauze, strips, films, powders, and other forms of these products are available. 

The India hemostat market is expected to grow due to an increasing geriatric population and increased adoption of hemostat products by medical practitioners. Due to a lack of awareness, medical practitioners and healthcare professionals have a low level of acceptance. As a result, raising awareness among key opinion leaders such as healthcare professionals may help the India hemostat market grow.

Covid-19 Impact

A majority of healthcare systems have postponed or cancelled non-essential medical procedures due to growing concerns about the spread of the novel coronavirus pandemic, COVID-19. This also includes surgical procedures like plastic surgery and others that aren’t directly related to the treatment or management of COVID-19 but are lifesaving and thus essential in nature. Regarding the competitive landscape, several medical device companies have withdrawn or revised their financial projections and revenue guidance for 2022. 

For example, Johnson & Johnson (Ethicon) expects a significant drop in surgical procedures in the second quarter of 2022, resulting in a 65 percent to 85 percent drop in revenue across all major markets. This is expected to have a negative impact on the global market.

Growth Drivers

Osteoporosis, lumbar spinal stenosis, GRD, arthritis, and BPH are common age-related diseases that often require surgery to improve joint function. These diseases can lead to intraoperative bleeding during knee replacement surgery, making hemostatic medications essential to control bleeding and prevent complications like hematoma formation and extended surgical procedures. These medications help reduce discomfort and improve joint function in patients with these conditions.

Restraining Factors

Low-quality hemostat products are the primary cause of side effects and allergic reactions, leading to infections that can prolong healing times and even cause death. In severed tendon healing, absorbable gelatin-based sponges can cause excessive fibrosis and protracted fixation. Inadequate products can affect end users’ perception of hemostat safety, reducing their acceptance and requiring substitutes.

Hemostats Market Segment Analysis

The global Hemostats market is segmented by set up product, application, end user and region. The market is divided into active, passive, combination, and other segments based on the product. The active segment is further divided into thrombin-based sealants and fibrin sealants. Plant, animal, and other segments can be sub-segmented within the passive segment. Because of the large number of product offerings and, in particular, the increased adoption of technologically advanced active products, the active and passive segments are expected to see strong CAGRs. Due to the increasing launch of cutting-edge products such as Baxter’s Floseal, the combination segment is expected to grow at the fastest rate during the forecast period. Based on application the market is divided into several applications, including trauma, cardiovascular surgery, general surgery, plastic surgery, orthopaedic surgery, neurosurgery, and others. Because of the increasing number of different types of surgical procedures, the general surgery segment is expected to dominate the application segment. During the forecast period, the cardiovascular and trauma segment is expected to have the highest CAGR. 

This can be attributed to factors such as the rising prevalence of cardiovascular diseases necessitating surgical intervention, as well as an increase in traumatic incidents, including accidents, around the world. During the forecast period, the cardiovascular surgery segment is expected to account for 20.0 percent of the market share. The increased prevalence of chronic diseases, increased demand for minimally invasive and aesthetic procedures, and significant improvements in healthcare infrastructure, combined with rising global expenditure, are expected to drive growth in the orthopaedic surgery, plastic surgery, and neurosurgery segments. 

The market is divided into hospitals and ASCs, tactical combat casualty care centres, and others based on end user. The critical reason for this segment’s dominance is that the majority of surgical procedures are performed in hospitals in both developed and developing countries due to the availability of such complex surgical tools and procedures. The tactical combat casualty care centre segment is being driven by increasing instances of military conflict necessitating the need for combat activities. During the forecast period, the tactical combat casualty care centres segment is expected to account for 5.2 percent of the global market. Other medical institutions that perform surgical procedures are included in the others segment, but the segment is expected to grow at a slower rate.

Top Key Players Profiled in the Hemostats Market

The hemostats market key players include C.R. Bard (US), Baxter (US), Teleflex Incorporated (US), Ethicon (Subsidiary of Johnson & Johnson) (US), Medtronic plc (Ireland), B. Braun Melsungen AG (Germany), Pfizer (US), etc. In 2020, Ethicon (Subsidiary of Johnson & Johnson) (US).

New Developments

November 15, 2023, Ethicon Introduces ETHIZIATM Hemostatic Sealing Patch, Clinically Proven to Stop Disruptive Bleeding. SEP 28, 2022, Medtronic Nexpowder™* Endoscopic Hemostasis System Receives U.S. FDA Clearance.

Hemostats Market Country-wise Insights

North America had the largest market share for Hemostats. The large share of North America is primarily driven by the region’s growing geriatric population, an increase in the number of surgeries performed, and the strong presence of major market players. Europe is the market’s second-leading region. This is due to factors such as high healthcare spending, which is driving a demand for technologically advanced products as a result of the high volume of surgeries. 

Asia Pacific is expected to have the highest CAGR due to a large patient population, an increase in surgical procedures, and an increase in product launches. The other two regions, Latin America and the Middle East and Africa, are expected to have lower market shares and growth rates. This can be attributed to factors such as significant increases in healthcare spending and infrastructure. Furthermore, the hemostats market is expected to benefit from a large potential patient population as the number of surgical procedures increases.

Segments Covered in the Hemostats Market

Hemostats Market by Product

• Active Hemostats
• Thrombin Based Hemostats
• Fibrin Sealants
• Passive Hemostats
• Plant
• Animal
• Others
• Combination Hemostats
• Others

Hemostats Market By Application

• Trauma
• Cardiovascular Surgery
• General Surgery
• Plastic Surgery
• Orthopedic Surgery
• Neurosurgery
• Others

Hemostats Market by End User

• Hospitals & ASCs
• Tactical Combat Casualty Care Centers
• Others

Frequently Ask Questions

What will the market be worth in the future?

The future market value for Hemostats market is expected USD 4.51 billion by 2030.

What is the growth rate of the Hemostats market?

Hemostats market is expected to grow at 6.6% CAGR from 2024 to 2030.

Who are the major players operating in the Hemostats market?The hemostats market key players include

C.R. Bard (US), Baxter (US), Teleflex Incorporated (US), Ethicon (Subsidiary of Johnson & Johnson) (US), Medtronic plc (Ireland), B. Braun Melsungen AG (Germany), Pfizer (US), etc. In 2020, Ethicon (Subsidiary of Johnson & Johnson) (US).

Table of Content

1. Introduction
   1. Market Definition
   2. Market Segmentation
   3. Research Timelines
   4. Assumptions and Limitations
2. Research Methodology
   1. Data Mining
      1. Secondary Research
      2. Primary Research
      3. Subject-Matter Experts’ Advice
   2. Quality Checks
      1. Final Review
   3. Data Triangulation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Research Flow
   4. Data Sources
3. Executive Summary
4. Market Overview
   1. Global Hemostats Market Outlook
      1. Market Drivers
      2. Market Restraints
      3. Market Opportunities
   2. Impact of Covid-19 On Hemostats Market
   3. Porter’s five forces model
      1. Threat from new entrants
      2. Threat from substitutes
      3. Bargaining power of suppliers
      4. Bargaining power of customers
      5. Degree of competition
   4. Industry value chain Analysis
5. Global Hemostats Market by Product
   1. Active Hemostats
   2. Thrombin Based Hemostats
   3. Fibrin Sealants
   4. Passive Hemostats
   5. Plant
   6. Animal
   7. Others
   8. Combination Hemostats
   9. Others
6. Global Hemostats Market by Application
   1. Trauma
   2. Cardiovascular Surgery
   3. General Surgery
   4. Plastic Surgery
   5. Orthopedic Surgery
   6. Neurosurgery
   7. Others
7. Global Hemostats Market by End User
   1. Hospitals & ASCs
   2. Tactical Combat Casualty Care Centers
   3. Others
8. Global Hemostats Market by Region
   1. North America
      1. US
      2. Canada
      3. Mexico
   2. South America
      1. Brazil
      2. Argentina
      3. Colombia
      4. Rest Of South America
   3. Europe
      1. Germany
      2. UK
      3. France
      4. Italy
      5. Spain
      6. Russia
      7. Rest Of Europe
   4. Asia Pacific
      1. India
      2. China
      3. Japan
      4. South Korea
      5. Australia
      6. South-East Asia
      7. Rest Of Asia Pacific
   5. Middle East and Africa
      1. UAE
      2. Saudi Arabia
      3. South Africa
      4. Rest Of Middle East and Africa

1. Company Profiles
   1. Baxter
   2. Integra LifeSciences Corporation
   3. Stryker
   4. CryoLife, Inc.
   5. Biom’up
   6. BD (Becton, Dickinson and Company)
   7. Medtronic
   8. Johnson & Johnson Services, Inc.
   9. Pfizer Inc.
   10. Others

List of Tables

Table 1                Global Hemostats Market By Product (USD Millions) 2023-2030 Table 2                Global Hemostats Market By Application (USD Millions) 2023-2030 Table 3                Global Hemostats Market By End User (USD Millions) 2023-2030 Table 4                Global Hemostats Market By Region (USD Millions) 2023-2030 Table 5                North America Hemostats Market By Country (USD Millions) 2019-2028 Table 6                Us Hemostats Market By Product (USD Millions) 2023-2030 Table 7                Us Market By Application (USD Millions) 2023-2030 Table 8                Us Market By End User (USD Millions) 2023-2030 Table 9                Canada Market By Product (USD Millions) 2023-2030 Table 10              Canada Market By Application (USD Millions) 2023-2030 Table 11              Canada Market By End User (USD Millions) 2023-2030 Table 12              Mexico Hemostats Market By Product (USD Millions) 2023-2030 Table 13              Mexico Market By Application (USD Millions) 2023-2030 Table 14              Mexico Market By End User (USD Millions) 2023-2030 Table 15              South America Hemostats Market By Country (USD Millions) 2019-2028 Table 16              Brazil Hemostats Market By Product (USD Millions) 2023-2030 Table 17              Brazil Market By Application (USD Millions) 2023-2030 Table 18              Brazil Market By End User (USD Millions) 2023-2030 Table 19              Argentina Hemostats Market By Product (USD Millions) 2023-2030 Table 20              Argentina Market By Application (USD Millions) 2023-2030 Table 21              Argentina Market By End User (USD Millions) 2023-2030 Table 22              Colombia Market By Product (USD Millions) 2023-2030 Table 23              Colombia Market By Application (USD Millions) 2023-2030 Table 24              Colombia Market By End User (USD Millions) 2023-2030 Table 25              Rest Of South America Hemostats Market By Product (USD Millions) 2023-2030 Table 26              Rest Of South America Market By Application (USD Millions) 2023-2030 Table 27              Rest Of South America Market By End User (USD Millions) 2023-2030 Table 28              Asia-Pacific Hemostats Market By Country (USD Millions) 2019-2028 Table 29              India Hemostats Market By Product (USD Millions) 2023-2030 Table 30              India Market By Application (USD Millions) 2023-2030 Table 31              India Hemostats Market By End User (USD Millions) 2023-2030 Table 32              China Hemostats Market By Product (USD Millions) 2023-2030 Table 33              China Market By Application (USD Millions) 2023-2030 Table 34              China Market By End User (USD Millions) 2023-2030 Table 35              Japan Hemostats Market By Product (USD Millions) 2023-2030 Table 36              Japan arket By Application (USD Millions) 2023-2030 Table 37              Japan Hemostats Market By End User (USD Millions) 2023-2030 Table 38              South Korea Hemostats Market By Product (USD Millions) 2023-2030 Table 39              South Korea arket By Application (USD Millions) 2023-2030 Table 40              South Korea Market By End User (USD Millions) 2023-2030 Table 41              Australia Hemostats Market By Product (USD Millions) 2023-2030 Table 42              Australia Market By Application (USD Millions) 2023-2030 Table 43              Australia Hemostats Market By End User (USD Millions) 2023-2030 Table 44              South-East Asia Hemostats Market By Product (USD Millions) 2023-2030 Table 45              South-East Asia Market By Application (USD Millions) 2023-2030 Table 46              South-East Asia Market By End User (USD Millions) 2023-2030 Table 47              Rest Of Asia Pacific Hemostats Market By Product (USD Millions) 2023-2030 Table 48              Rest Of Asia Pacific Market By Application (USD Millions) 2023-2030 Table 49              Rest Of Asia Pacific Market By End User (USD Millions) 2023-2030 Table 50              Europe Hemostats Market By Country (USD Millions) 2019-2028 Table 51              Germany Hemostats Market By Product (USD Millions) 2023-2030 Table 52              Germany Market By Application (USD Millions) 2023-2030 Table 53              Germany Market By End User (USD Millions) 2023-2030 Table 54              Uk Hemostats Market By Product (USD Millions) 2023-2030 Table 55              Uk Market By Application (USD Millions) 2023-2030 Table 56              Uk Market By End User (USD Millions) 2023-2030 Table 57              France Hemostats Market By Product (USD Millions) 2023-2030 Table 58              France Market By Application (USD Millions) 2023-2030 Table 59              France Hemostats Market By End User (USD Millions) 2023-2030 Table 60              Italy Hemostats Market By Product (USD Millions) 2023-2030 Table 61              Italy Market By Application (USD Millions) 2023-2030 Table 62              Italy Market By End User (USD Millions) 2023-2030 Table 63              Spain Hemostats Market By Product (USD Millions) 2023-2030 Table 64              Spain Market By Application (USD Millions) 2023-2030 Table 65              Spain Hemostats Market By End User (USD Millions) 2023-2030 Table 66              Russia Hemostats Market By Product (USD Millions) 2023-2030 Table 67              Russia Market By Application (USD Millions) 2023-2030 Table 68              Russia Hemostats Market By End User (USD Millions) 2023-2030 Table 69              Rest Of Europe Hemostats Market By Product (USD Millions) 2023-2030 Table 70              Rest Of Europe Market By Application (USD Millions) 2023-2030 Table 71              Rest Of Europe Market By End User (USD Millions) 2023-2030 Table 72              Middle East And Africa Hemostats Market By Country (USD Millions) 2019-2028 Table 73              Uae Hemostats Market By Product (USD Millions) 2023-2030 Table 74              Uae Market By Application (USD Millions) 2023-2030 Table 75              Uae Market By End User (USD Millions) 2023-2030 Table 76              Saudi Arabia Market By Product (USD Millions) 2023-2030 Table 77              Saudi Arabia Market By Application (USD Millions) 2023-2030 Table 78              Saudi Arabia Market By End User (USD Millions) 2023-2030 Table 79              South Africa Market By Product (USD Millions) 2023-2030 Table 80              South Africa Market By Application (USD Millions) 2023-2030 Table 81              South Africa Market By End User (USD Millions) 2023-2030 Table 82              Rest Of Middle East And Africa Hemostats Market By Product (USD Millions) 2023-2030 Table 83              Rest Of Middle East And Africa Market By Application (USD Millions) 2023-2030 Table 84              Rest of Middle East and Africa Market By End User (USD Millions) 2023-2030

List of Figures

Figure 1         Market Dynamics Figure 2         Market Segmentation Figure 3         Report Timelines: Years Considered Figure 4         Data Triangulation Figure 5         Bottom-Up Approach Figure 6         Top-Down Approach Figure 7         Research Flow Figure 8         Global Hemostats Market By Product, USD Million, 2023-2030 Figure 9         Global Market By Application, USD Million, 2023-2030 Figure 10       Global Market By End User, USD Million, 2023-2030 Figure 11       Global Market By Region, USD Million, 2023-2030 Figure 12       Porter’s Five Forces Model Figure 13       North America Market Snapshot Figure 14       Europe Market Snapshot Figure 15       Asia Pacific Market Snapshot Figure 16       South America Market Snapshot Figure 17       Middle East & Africa Market Snapshot Figure 18       Baxter: Company Snapshot Figure 19       Integra Lifesciences Corporation: Company Snapshot Figure 20       Stryker: Company Snapshot Figure 21       Cryolife, Inc.: Company Snapshot Figure 22       Biom’up: Company Snapshot Figure 23       Bd (Becton, Dickinson And Company): Company Snapshot Figure 24       Medtronic: Company Snapshot Figure 25       Johnson & Johnson Services, Inc.: Company Snapshot Figure 26       Pfizer Inc.: Company Snapshot Figure 27      Others: Company Snapshot